MPI Research is pleased to announce the promotion of Chris Papagiannis, B.S. to the position of Study Director. In this new capacity, he will be responsible for proposal preparation and the conduct, evaluation, and scientific reporting of toxicology studies.

David G. Serota, Ph.D., D.A.B.T., Director of Toxicology, commented, “While serving as an Associate Study Director, Chris has demonstrated good organizational and communication skills, with a full understanding of the fundamentals of the discipline of toxicology. He works well with his Sponsors and has earned their respect and confidence. This promotion recognizes his scientific ability and his commitment to quality research and customer satisfaction.”

MPI Research exists to provide comprehensive non-clinical research that meets the requirements of pharmaceutical, animal health and chemical companies as well as governmental agencies as we partner together to bring safer, healthier products to the world. MPI employees specialize in a wide variety of scientific disciplines including toxicology, pharmacology, metabolism, pathology, clinical pathology, reproductive and developmental biology, veterinary science, neuroscience, analytical chemistry, computer science, regulatory science, and statistics.

Home | News